Nipent

Product manufactured by Hospira, Inc.

Application Nr Approved Date Route Status External Links
NDA020122 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Nipent Is Indicated As Single-Agent Treatment For Both Untreated And Alpha-Interferon-Refractory Hairy Cell Leukemia Patients With Active Disease As Defined By Clinically Significant Anemia, Neutropenia, Thrombocytopenia, Or Disease-Related Symptoms.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pentostatin PENTOSTATIN ZINC3806262

Comments